INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Nov 01, 2006 |
SVP, Therap & Clin Prog Dev
|
SVP, Therap & Clin Prog Dev | Form 4 | Open market or private sale of non-derivative or derivative security | 5,760 | $20.00 | 3,887 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 165 | $17.53 | 3,907 |
| Feb 06, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 500 | $16.01 | 4,027 |
| Dec 16, 2022 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,063 | -- | 4,063 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 29 | $17.52 | 4,072 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 72 | $17.50 | 4,101 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 86 | $17.14 | 4,173 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 14 | $17.04 | 4,259 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 143 | $17.02 | 4,273 |
| Oct 01, 2008 |
SVP, Research & Devel Sciences
|
SVP, Research & Devel Sciences | Form 4 | Other acquisition or disposition | -- | -- | 4,275 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.